Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06369701 · ClinicalTrials.gov registry record · NA

Effects Compressive Tissue Flossing on Lateral Elbow Tendinopathy in US Service Members

A NA study of Lateral Elbow Tendinopathy, sponsored by Brooke Army Medical Center.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT06369701 is a NA study of Lateral Elbow Tendinopathy that has completed, run by Brooke Army Medical Center. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06369701, a NA study of Lateral Elbow Tendinopathy, has completed, sponsored by Brooke Army Medical Center.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study will be to assess the effects of a compressive tissue flossing (CTF) program on the symptoms of lateral elbow tendinopathy in United States service members. Dependent variables will be the Defense and Veteran's Pain Rating Scale (DVPRS), decrease their Patient-Rated Tennis Elbow Evaluation (PRTEE) score, increase their maximal grip strength in the affected upper extremity (UE). Measurements will be taken at baseline, immediately after the first CTF intervention, and at the 1-week follow-up, for a total of 3 measurements.

Conditions Studied

Interventions

  • DEVICE Compressive tissue floss band

Study Locations (1)

Texas

  • Brooke Army Medical Center - Fort Sam Houston

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2024-02-13
Est. Completion 2024-05-01
Phase NA

Sponsor

Brooke Army Medical Center

54 total trials

What the Registry Record Tells You About NCT06369701

The ClinicalTrials.gov registry entry for NCT06369701 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lateral Elbow Tendinopathy appearing as the primary indexed condition, and to 1 intervention - of which Compressive tissue floss band is the first listed.

NCT06369701 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06369701 about?

NCT06369701 is a clinical study titled "Effects Compressive Tissue Flossing on Lateral Elbow Tendinopathy in US Service Members". The purpose of this research study will be to assess the effects of a compressive tissue flossing (CTF) program on the symptoms of lateral elbow tendinopathy in United States service members. Dependent variables will be the Defense and Veteran's Pain Rating Scale (DVPRS), decrease their Patient-Rate...

What is the current status of trial NCT06369701?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2024-02-13. Estimated completion is 2024-05-01.

What conditions does trial NCT06369701 study?

This clinical trial studies the following conditions: Lateral Elbow Tendinopathy.

What interventions are being tested in trial NCT06369701?

The interventions under investigation include: Compressive tissue floss band (DEVICE).

Who is sponsoring clinical trial NCT06369701?

This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06369701 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lateral Elbow Tendinopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.